18 Liraglutide has been shown to activate AMPK in rat vascular smooth muscle cells
So uh I mean, I I forget when the company reports, but I guess we'll find out when they report exactly um you know, how they're holding up against Lily just to be real quick
doi: 10.1016/j.cmet.2024.05.001
The two are grouped in research and search behavior mainly because both are studied in metabolic and fat-loss contexts, not because they share a biological pathway
More than half of all adverse drug events were classified as not serious
Additionally, both semaglutide and tirzepatide showed promise in improving metabolic dysfunction-associated steatotic liver disease (MASLD), mitigating systemic inflammation, and contributing to improvements in liver-related outcomes, including steatosis resolution and fibrosis-related endpoints, in clinical trials